Managing hyperparathyroidism involves a variety of clinical approaches tailored to the severity of the condition and the specific needs of the patient. The primary goal of treatment is to restore the balance of calcium and parathyroid hormone in the body, thereby preventing long term complications such as bone density loss and kidney stones. While surgery is the only definitive cure for primary hyperparathyroidism, other options including medication and active monitoring are available for those who do not require or cannot undergo an operation. Each pathway is designed to ensure the patient remains safe while addressing the physiological disruptions caused by overactive parathyroid glands.
What We’ll Discuss in This Article
- The clinical criteria and success rates for parathyroidectomy surgery.
- How calcimimetic medications work to lower blood calcium levels.
- The use of bisphosphonates to protect skeletal integrity in mineral disorders.
- The requirements for the active monitoring or “watch and wait” approach.
- Emergency management protocols for severe or acute hypercalcaemia.
- Postoperative care and long term monitoring of mineral levels.
Surgical Removal of Abnormal Glands (Parathyroidectomy)
Surgical intervention is the primary and most effective treatment for hyperparathyroidism when it is caused by one or more overactive parathyroid glands. This procedure, known as a parathyroidectomy, involves the identified removal of the abnormal tissue that is producing excessive amounts of hormone. Clinical data shows that this operation has a success rate of approximately ninety-seven percent in curing primary hyperparathyroidism. By removing the source of the hormonal imbalance, the body is able to naturally reset its calcium levels and stop the progressive leaching of minerals from the skeleton.
The decision to offer surgery is based on specific clinical criteria established by UK health authorities. The National Institute for Health and Care Excellence recommends surgery for individuals who have symptomatic hyperparathyroidism or for those whose blood calcium levels have reached a specific threshold above the normal range. Other indications for surgery include the presence of kidney stones, evidence of impaired kidney function, or a significant decrease in bone mineral density as measured by a DEXA scan. Furthermore, surgery is often recommended for patients under the age of fifty regardless of symptoms because they have a higher lifetime risk of developing complications from chronic hypercalcaemia.
During the procedure, the surgeon may perform a focused parathyroidectomy if imaging has successfully located a single abnormal gland, usually a benign adenoma. If the location is not certain or if multiple glands are suspected to be involved, a more comprehensive exploration of the neck is performed to ensure all overactive tissue is found. Following a successful operation, blood calcium levels typically return to the healthy range within twenty-four to forty-eight hours. Most patients experience a significant improvement in symptoms such as fatigue and cognitive “fog” within weeks of the procedure.
Medication Options for Symptom Management (Calcimimetics)
For patients who are not suitable candidates for surgery or who choose not to undergo an operation, medication is the primary alternative for managing elevated calcium. The most common type of medication used for this purpose is a class of drugs called calcimimetics, with cinacalcet being the most frequently prescribed in the United Kingdom. Calcimimetics work by increasing the sensitivity of the calcium sensing receptors on the parathyroid glands. This effectively “tricks” the glands into believing that blood calcium levels are higher than they actually are, which causes them to reduce the secretion of parathyroid hormone.
Cinacalcet is particularly effective at lowering blood calcium and reducing the symptoms associated with hypercalcaemia, such as excessive thirst and nausea. It is often used for patients with very high calcium levels who are not surgical candidates or for those with parathyroid carcinoma. According to NHS clinical commissioning policies, cinacalcet is a recognised treatment option for patients with primary hyperparathyroidism where surgery has failed or is clinically inappropriate. It is important to note that while cinacalcet is excellent at controlling calcium levels, it does not typically improve bone mineral density. Therefore, patients on this medication may still require additional treatments to protect their skeletal health.
The use of cinacalcet requires careful monitoring through regular blood tests. When a patient first begins the medication, their calcium levels are usually checked weekly or fortnightly until a stable dose is reached. Once the levels are within a target range, monitoring can often be reduced to every few months. The most common side effect reported by patients taking calcimimetics is nausea, which is often mild and can be managed by taking the medication with food. If the medication is stopped, the calcium levels will typically rise again, as the drug manages the symptoms rather than curing the underlying glandular overactivity.
Protecting Bone Density with Bisphosphonates
While surgery and calcimimetics focus on the hormonal and chemical aspects of hyperparathyroidism, bisphosphonates are used to address the skeletal consequences of the condition. In individuals with overactive parathyroid glands, the constant presence of excess hormone signals the body to break down bone tissue to release calcium into the blood. This leads to a progressive thinning of the bones, known as osteoporosis. Bisphosphonates, such as alendronic acid, are medications that slow down the rate at which bone is broken down, helping to preserve the structural integrity of the skeleton.
Bisphosphonates do not significantly lower blood calcium or parathyroid hormone levels, but they are vital for reducing the risk of fragility fractures. These medications are often prescribed for patients with hyperparathyroidism who already show signs of bone thinning or for those who are waiting for surgery. They work by binding to the surface of the bone and inhibiting the activity of osteoclasts, which are the cells responsible for bone resorption. This allows the bone building cells more time to strengthen the bone matrix.
Patients taking oral bisphosphonates must follow strict administration instructions to ensure the drug is absorbed correctly and to avoid irritation of the food pipe. This typically involves taking the tablet on an empty stomach with a full glass of plain water and remaining upright for at least thirty minutes afterwards. For patients who cannot tolerate oral medications, intravenous versions such as zoledronic acid may be offered. By including bisphosphonates in the treatment plan, clinicians can help mitigate the long term physical impact of the calcium disorder while the primary issue is being managed or monitored.
The Active Monitoring Approach (Watch and Wait)
Not every patient with hyperparathyroidism requires immediate medical or surgical intervention. For individuals who have no symptoms and whose calcium levels are only mildly elevated, a “watch and wait” approach, also known as active monitoring, may be appropriate. This strategy involves regular clinical reviews and biochemical testing to ensure that the condition is not progressing or causing silent damage to the organs. This is often the preferred pathway for older patients or those with other significant health conditions where the risks of surgery might outweigh the immediate benefits.
Active monitoring requires a commitment to periodic blood tests to track serum calcium and kidney function. Usually, these tests are performed every six to twelve months. In addition to blood work, patients are typically advised to undergo a bone density scan every two to three years to check for any significant loss of bone mineral. If the monitoring shows that the calcium levels are rising or that the kidneys and bones are being negatively affected, the clinical team will then reconsider more active treatment options like surgery or medication.
During the monitoring phase, patients are encouraged to maintain a healthy lifestyle to support their mineral balance. This includes drinking plenty of fluids to stay hydrated, which helps the kidneys process calcium, and avoiding a diet that is excessively high or low in calcium. The National Institute for Health and Care Excellence provides clear guidance on how monitoring should be conducted to ensure that any changes in the patient’s condition are caught early. This conservative approach allows many people to live comfortably for years without needing invasive procedures, provided they remain under the careful supervision of a specialist.
Management of Acute and Severe Hypercalcaemia
In rare cases, hyperparathyroidism can lead to a sudden and dangerous rise in blood calcium, a condition known as acute hypercalcaemia. This is a medical emergency that requires urgent hospital treatment to prevent serious complications such as heart rhythm disturbances or kidney failure. Severe hypercalcaemia is generally defined as an adjusted calcium level of 3.4 mmol/L or higher. Patients experiencing this may become very confused, drowsy, or severely dehydrated.
The first step in treating acute hypercalcaemia is aggressive rehydration through intravenous fluids. By increasing the volume of fluid in the body, the kidneys are able to flush out more calcium through the urine. Once the patient is hydrated, they may be given intravenous bisphosphonates, which act quickly to stop the release of calcium from the bones. In some cases, calcimimetics may also be started to rapidly suppress the parathyroid glands. This intensive management is designed to stabilise the patient as quickly as possible so that the underlying cause can be addressed.
After the emergency has passed and the calcium levels have been brought down to a safer range, the clinical team will evaluate the patient for definitive treatment. This often involves planning for an urgent parathyroidectomy if the patient is well enough for surgery. The goal of emergency treatment is to prevent the life threatening effects of high calcium while preparing the body for the long term solution of removing the abnormal gland. Constant monitoring of electrolytes and heart function is a standard part of this critical care process.
Conclusion
Treatments for hyperparathyroidism range from the definitive cure of surgical parathyroidectomy to the management of symptoms through calcimimetic medications and the protection of bone health with bisphosphonates. For mild cases, a strategy of active monitoring allows for safe observation over time. The chosen pathway depends on the severity of the calcium elevation and the presence of symptoms or complications. If you experience severe, sudden, or worsening symptoms, call 999 immediately.
How long does it take to recover from parathyroid surgery?
Most patients recover quickly and can return to their normal activities within one to two weeks, although they will need regular blood tests in the early weeks to ensure their calcium levels are stable.
Can I manage my hyperparathyroidism with diet alone?
No, while a balanced diet is important, you should not try to lower your calcium levels through diet unless specifically told to do so by a specialist, as this can lead to other mineral imbalances.
What happens if I cannot have surgery?
If surgery is not an option, you can be managed effectively with medications like cinacalcet to lower your calcium and bisphosphonates to protect your bones, alongside regular monitoring.
Do parathyroid glands always need to be removed?
They only need to be removed if they are overactive and causing high calcium levels that are symptomatic or posing a risk to your bone and kidney health.
Will my symptoms go away immediately after treatment?
Many patients notice an improvement in symptoms like fatigue and confusion very shortly after their calcium levels are corrected, though bone density recovery takes much longer.
Are there any long term risks of taking cinacalcet?
The main side effect is nausea, and long term use requires regular monitoring of calcium levels to ensure they do not fall too low, a condition known as hypocalcaemia.
Is parathyroid surgery performed under a general anaesthetic?
Yes, the operation is almost always performed while you are asleep under general anaesthesia to ensure you are comfortable and still during the procedure.
Authority Snapshot (E-E-A-T)
The MyPatientAdvice Medical Content Team provides evidence-based patient education strictly aligned with UK clinical standards. This article has been reviewed by Dr. Stefan Petrov, a UK-trained physician with experience in internal medicine, surgery, and emergency care. All information regarding the treatment of hyperparathyroidism is grounded in the established safety and clinical guidelines provided by the NHS and the National Institute for Health and Care Excellence (NICE).
